Alberto Savrieno
Alberto Savrieno
Send Message
Alberto Savrieno
Stop FollowingAlberto Savrieno
View as an RSS Feed
- Market Running On Fumes, Prepare Your Exit Strategy
- Athersys Has Some Promise, But Controversy And Doubt Remain
- Pandora, Groupon, Zynga And Mobivity: Hard Numbers Show They're Turning A Corner
- The Bottom Is In For Gold And Mining Stocks
- New Developments In Ophthalmology Indicate Likely Surprises
- Some Lesser Known Healthcare Prospects For 2013
- Technology Revolution To Shape EV Charging Landscape
- Pershing Gold Is A Good Guy And Great Buy, But Not For The Reasons You Think
- Gold Stocks Are A Minefield, Pun Intended
- How To Invest In Patent Holding Companies
- Catching The Tail End Of Nutritional Supplements' Massive 3 Year Run
- The Fed's Powder Keg Is Locked And Loaded - Gold Armor Is The Best Defense
- Trius Therapeutics: Treatment And Stock Undervalued
- Not Enough Cash For Sunshine Heart
- Pfizer, Novartis And Northwest Biotherapeutics In A Race For IVF Inspired Cancer Cure
- What Does The U.S. Trade Deficit Have To Do With Chinese Education?
- An Acquisition Opportunity For Small Players With The Right Stuff
- Opko, Bristol-Myers, Teva And A Frosty Debate In The Mix
- Hooters Vs. McDonald's, Chanticleer's Fast Food American Dream
- The Hidden Value In Electric Vehicle Infrastructure
- The Israel Discount - An Opportunity To Pick Up Teva, Prolor Cheap
- Colony Collapse Disorder As Part Of An Acquisition Strategy
